Asian‐type DEL ( RHD*DEL1 ) with an allo‐anti‐D: A paradoxical observation in a healthy multiparous woman
Transfusion · 2023
DOI: 10.1111/trf.17465 ↗Kurz gefasst
Fallbericht in der Zeitschrift Transfusion, 2023. Verfasst von Hitoshi Ohto und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Mesenchymal Stem Cell Research, Fukushima Medical University, Fukushima, Japan. Hauptthemen laut MEDLINE: Rh-Hr Blood-Group System, Rho(D) Immune Globulin. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Intramural NIH HHS, Ministry of Education, Culture, Sports, Science and Technology, NIH Clinical Center.
Abstract (Originalsprache)
Background
The DEL phenotype is the D variant expressing the least amounts of D antigen per red cell. Asian‐type DEL ( RHD : c:1227G > A ) is the most prevalent DEL in East Asia without any anti‐D alloimmunization reported before. We investigated the first observation of an anti‐D in any DEL phenotype, reported in the Japanese language at a 1987 conference, only 3 years after the discovery of DEL.
Methods
We contacted the proband 35 years after the initial report. Standard hemagglutination, adsorption/elution, and flow cytometry tests were performed, as was nucleotide sequencing for the RHD , RHCE , and HLA class I and class II genes.
Results
The healthy multiparous Japanese woman, a regular blood donor, still had the anti‐D of titer 8 representing an alloantibody by standard serologic methods. Unexpectedly, she carried an Asian‐type DEL without any additional RHD gene variation. All 12 HLA alleles identified were known in the Japanese population. Interestingly, one of her HLA‐DRB1 and a variant of her HLA‐DQB1 alleles had previously been associated with anti‐D immunization.
Conclusion
We described an allo‐anti‐D, maintained for more than three decades, in an Asian‐type DEL. The combination of two implicated HLA alleles were rare and could have contributed to the anti‐D immunization. Continued monitoring of anti‐D immunization events in patients with DEL is warranted, and we discuss possible mechanisms for further study. As only this single observation has been recognized in the last 35 years, the current recommendation is affirmed: Individuals with Asian‐type DEL should be treated as Rh D‐positive for transfusion and Rh immune prophylaxis purposes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Mesenchymal Stem Cell Research, Fukushima Medical University, Fukushima, Japan.
- Tohoku Block Blood Center, Japanese Red Cross Society, Sendai, Japan.
- Department of Transfusion Medicine, NIH Clinical Center, National Institutes of Health, Bethesda, Maryland, USA.
- Kanto-Koshinetsu Block Blood Center, Japanese Red Cross Society, Tokyo, Japan.
- Department of Blood Transfusion and Transplantation Immunology, Fukushima Medical University School of Medicine, Fukushima, Japan.
ORCID-Profile: Hitoshi Ohto, Kshitij Srivastava, Willy Albert Flegel
Förderung
- Intramural NIH HHS
- Ministry of Education, Culture, Sports, Science and Technology
- NIH Clinical Center
Zitieren
APA
Ohto, H., Ito, S., Srivastava, K., Ogiyama, Y., Uchikawa, M., Nollet, K. E., & Flegel, W. A. (2023). Asian‐type DEL ( RHD*DEL1 ) with an allo‐anti‐D: A paradoxical observation in a healthy multiparous woman. Transfusion. https://doi.org/10.1111/trf.17465
Vancouver
Ohto H, Ito S, Srivastava K, Ogiyama Y, Uchikawa M, Nollet KE, et al. Asian‐type DEL ( RHD*DEL1 ) with an allo‐anti‐D: A paradoxical observation in a healthy multiparous woman. Transfusion. 2023. doi:10.1111/trf.17465
BibTeX
@article{Ohto2023,
author = {Ohto, Hitoshi and Ito, Shoichi and Srivastava, Kshitij and Ogiyama, Yoshiko and Uchikawa, Makoto and Nollet, Kenneth Eric and Flegel, Willy Albert},
title = {Asian‐type DEL ( RHD*DEL1 ) with an allo‐anti‐D: A paradoxical observation in a healthy multiparous woman},
journal = {Transfusion},
year = {2023},
doi = {10.1111/trf.17465}
}
EUVIMED